This was the stock's second consecutive day of losses.

Synchrony Financial said on Tuesday it expects lower net revenue for 2025 as spending levels moderate and interest rates dip, ...

Good morning, and welcome to the Synchrony Financial fourth quarter and full year 2024 earnings conference call. Please refer ...

Synchrony Financial closed 1.51% below its 52-week high of $70.93, which the company reached on January 23rd.

Synchrony Financial's fourth-quarter earnings results missed analysts' forecasts and investors pummeled the stock due to a ...

In a report released yesterday, Moshe Orenbuch from TD Cowen maintained a Buy rating on Synchrony Financial (SYF – Research Report), with a ...

Synchrony Financial's fourth-quarter profit and revenue came up short of forecasts on higher costs and less-than-expected net interest income.

Synchrony Financial reported Q4 results with a Y/Y increase in net interest income, driven by higher interest and fees on ...

Compass Point downgraded Synchrony (SYF) to Neutral from Buy with a $70 price target Invest with Confidence: Follow TipRanks' Top Wall Street ...

Synchrony Financial (NYSE: SYF) today announced its fourth quarter 2024 results for the period ending December 31, 2024. The earnings news release and presentation can be found on the company's invest ...

Synchrony Financial (SYF) stock drops after Q4 earnings miss analyst estimates, with weaker net interest income and higher credit losses.

Akero Therapeutics reports a 39% improvement in cirrhosis patients using EFX. See why AKRO stock is soaring with the ...